US Stock MarketDetailed Quotes

AVIR Atea Pharmaceuticals

Watchlist
  • 3.710
  • +0.020+0.54%
Close Apr 26 16:00 ET
  • 3.710
  • 0.0000.00%
Post 16:20 ET
312.47MMarket Cap-2276P/E (TTM)

Atea Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
29.42%-85.4M
-1.34%-21.83M
17.19%-17.59M
15.98%-16.12M
49.41%-29.85M
-39.05%-120.98M
71.43%-21.55M
-193.98%-21.24M
-10.59%-19.19M
-250.47%-59.01M
Net income from continuing operations
-17.30%-135.96M
-13.75%-39.16M
-310.89%-33.14M
10.06%-28.18M
15.71%-35.47M
-195.64%-115.91M
-129.40%-34.43M
71.39%-8.07M
-2,136.06%-31.34M
-237.00%-42.08M
Depreciation and amortization
60.00%416K
0.00%104K
-1.89%104K
141.86%104K
1,385.71%104K
796.55%260K
1,385.71%104K
1,414.29%106K
437.50%43K
0.00%7K
Other non cash items
----
----
----
----
----
----
----
----
----
--16K
Change In working capital
134.69%16.16M
127.56%9.41M
133.07%7.38M
1,443.46%3.3M
86.25%-3.94M
81.20%-46.59M
102.03%4.14M
-156.08%-22.32M
100.74%214K
47.81%-28.62M
-Change in prepaid assets
129.82%1.86M
-135.37%-4.16M
161.19%4.57M
-131.74%-862K
740.36%2.31M
-1,194.20%-6.25M
62.74%-1.77M
-648.02%-7.48M
55.73%2.72M
-76.11%275K
-Change in payables and accrued expense
136.26%14.36M
366.39%13.61M
127.66%2.85M
216.97%3.91M
79.20%-6.01M
-173.12%-39.61M
141.36%2.92M
-148.59%-10.29M
-111.26%-3.34M
-378.87%-28.89M
-Change in other current assets
106.56%98K
--0
--0
--295K
---197K
-827.95%-1.49M
-2,363.64%-1.49M
--0
--0
--0
-Change in other current liabilities
-121.05%-161K
-17.14%-41K
0.00%-40K
-104.64%-39K
---41K
--765K
---35K
---40K
--840K
--0
Cash from discontinued investing activities
Operating cash flow
29.42%-85.4M
-1.34%-21.83M
17.19%-17.59M
15.98%-16.12M
49.41%-29.85M
-39.05%-120.98M
71.43%-21.55M
-193.98%-21.24M
-10.59%-19.19M
-250.47%-59.01M
Investing cash flow
Cash flow from continuing investing activities
108.85%40.3M
-17.07%27.77M
87.98%-58.51M
2,578.18%46.57M
55,736.36%24.48M
-11,385,150.00%-455.41M
837,300.00%33.49M
-486.98M
-1.88M
-44K
Net PPE purchase and sale
--0
--0
--0
--0
--0
-48,475.00%-1.94M
--0
---20K
---1.88M
---44K
Net investment purchase and sale
108.89%40.3M
-17.07%27.77M
87.98%-58.51M
--46.57M
--24.48M
---453.47M
--33.49M
---486.96M
--0
--0
Cash from discontinued investing activities
Investing cash flow
108.85%40.3M
-17.07%27.77M
87.98%-58.51M
2,578.18%46.57M
55,736.36%24.48M
-11,385,150.00%-455.41M
837,300.00%33.49M
---486.98M
---1.88M
---44K
Financing cash flow
Cash flow from continuing financing activities
-30.54%257K
0
-37.41%92K
0
-26.01%165K
-74.74%370K
0
-81.51%147K
0
-52.65%223K
Proceeds from stock option exercised by employees
-30.54%257K
--0
-37.41%92K
--0
-26.01%165K
--370K
--0
-81.51%147K
--0
-52.65%223K
Cash from discontinued financing activities
Financing cash flow
-30.54%257K
--0
-37.41%92K
--0
-26.01%165K
-74.74%370K
--0
-81.51%147K
--0
-52.65%223K
Net cash flow
Beginning cash position
-75.33%188.66M
-21.97%137.89M
-68.76%213.9M
-74.01%183.45M
-75.33%188.66M
-10.06%764.68M
-78.96%176.72M
-16.14%684.79M
-15.35%705.85M
-10.06%764.68M
Current changes in cash
92.22%-44.84M
-50.29%5.94M
85.04%-76.01M
244.53%30.45M
91.15%-5.21M
-573.36%-576.02M
115.86%11.94M
-2,271.42%-508.07M
-21.83%-21.07M
-259.46%-58.83M
End cash Position
-23.77%143.82M
-23.77%143.82M
-21.97%137.89M
-68.76%213.9M
-74.01%183.45M
-75.33%188.66M
-75.33%188.66M
-78.96%176.72M
-16.14%684.79M
-15.35%705.85M
Free cash flow
30.53%-85.4M
-1.34%-21.83M
17.27%-17.59M
23.47%-16.12M
49.45%-29.85M
-41.28%-122.93M
71.44%-21.55M
-194.07%-21.26M
-21.43%-21.07M
-250.73%-59.05M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 29.42%-85.4M-1.34%-21.83M17.19%-17.59M15.98%-16.12M49.41%-29.85M-39.05%-120.98M71.43%-21.55M-193.98%-21.24M-10.59%-19.19M-250.47%-59.01M
Net income from continuing operations -17.30%-135.96M-13.75%-39.16M-310.89%-33.14M10.06%-28.18M15.71%-35.47M-195.64%-115.91M-129.40%-34.43M71.39%-8.07M-2,136.06%-31.34M-237.00%-42.08M
Depreciation and amortization 60.00%416K0.00%104K-1.89%104K141.86%104K1,385.71%104K796.55%260K1,385.71%104K1,414.29%106K437.50%43K0.00%7K
Other non cash items --------------------------------------16K
Change In working capital 134.69%16.16M127.56%9.41M133.07%7.38M1,443.46%3.3M86.25%-3.94M81.20%-46.59M102.03%4.14M-156.08%-22.32M100.74%214K47.81%-28.62M
-Change in prepaid assets 129.82%1.86M-135.37%-4.16M161.19%4.57M-131.74%-862K740.36%2.31M-1,194.20%-6.25M62.74%-1.77M-648.02%-7.48M55.73%2.72M-76.11%275K
-Change in payables and accrued expense 136.26%14.36M366.39%13.61M127.66%2.85M216.97%3.91M79.20%-6.01M-173.12%-39.61M141.36%2.92M-148.59%-10.29M-111.26%-3.34M-378.87%-28.89M
-Change in other current assets 106.56%98K--0--0--295K---197K-827.95%-1.49M-2,363.64%-1.49M--0--0--0
-Change in other current liabilities -121.05%-161K-17.14%-41K0.00%-40K-104.64%-39K---41K--765K---35K---40K--840K--0
Cash from discontinued investing activities
Operating cash flow 29.42%-85.4M-1.34%-21.83M17.19%-17.59M15.98%-16.12M49.41%-29.85M-39.05%-120.98M71.43%-21.55M-193.98%-21.24M-10.59%-19.19M-250.47%-59.01M
Investing cash flow
Cash flow from continuing investing activities 108.85%40.3M-17.07%27.77M87.98%-58.51M2,578.18%46.57M55,736.36%24.48M-11,385,150.00%-455.41M837,300.00%33.49M-486.98M-1.88M-44K
Net PPE purchase and sale --0--0--0--0--0-48,475.00%-1.94M--0---20K---1.88M---44K
Net investment purchase and sale 108.89%40.3M-17.07%27.77M87.98%-58.51M--46.57M--24.48M---453.47M--33.49M---486.96M--0--0
Cash from discontinued investing activities
Investing cash flow 108.85%40.3M-17.07%27.77M87.98%-58.51M2,578.18%46.57M55,736.36%24.48M-11,385,150.00%-455.41M837,300.00%33.49M---486.98M---1.88M---44K
Financing cash flow
Cash flow from continuing financing activities -30.54%257K0-37.41%92K0-26.01%165K-74.74%370K0-81.51%147K0-52.65%223K
Proceeds from stock option exercised by employees -30.54%257K--0-37.41%92K--0-26.01%165K--370K--0-81.51%147K--0-52.65%223K
Cash from discontinued financing activities
Financing cash flow -30.54%257K--0-37.41%92K--0-26.01%165K-74.74%370K--0-81.51%147K--0-52.65%223K
Net cash flow
Beginning cash position -75.33%188.66M-21.97%137.89M-68.76%213.9M-74.01%183.45M-75.33%188.66M-10.06%764.68M-78.96%176.72M-16.14%684.79M-15.35%705.85M-10.06%764.68M
Current changes in cash 92.22%-44.84M-50.29%5.94M85.04%-76.01M244.53%30.45M91.15%-5.21M-573.36%-576.02M115.86%11.94M-2,271.42%-508.07M-21.83%-21.07M-259.46%-58.83M
End cash Position -23.77%143.82M-23.77%143.82M-21.97%137.89M-68.76%213.9M-74.01%183.45M-75.33%188.66M-75.33%188.66M-78.96%176.72M-16.14%684.79M-15.35%705.85M
Free cash flow 30.53%-85.4M-1.34%-21.83M17.27%-17.59M23.47%-16.12M49.45%-29.85M-41.28%-122.93M71.44%-21.55M-194.07%-21.26M-21.43%-21.07M-250.73%-59.05M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg